Related Experiment Video
Updated: May 3, 2026

12:10
Retzius-Sparing Robot-Assisted Radical Prostatectomy
Published on: May 19, 2022
9.6K
Simultaneous robot-assisted laparoendoscopic single-site partial nephrectomy and standard radical prostatectomy
Jae Hung Jung1, Hong Wook Kim, Cheol Kyu Oh
1Department of Urology, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea. khrha@yuhs.ac.
Yonsei Medical Journal
|February 18, 2014
Summary
Robot-assisted surgery now treats multiple urologic cancers simultaneously. This study explores the feasibility of combining robot-assisted laparoendoscopic single-site surgery partial nephrectomy with standard radical prostatectomy for patients with synchronous conditions.
Area of Science:
- Urologic oncology
- Minimally invasive surgery
- Robotic surgery
Background:
- Robot-assisted surgery is increasingly used for urologic malignancies.
- Advanced applications include treating patients with multiple concomitant urologic malignancies.
- Robot-assisted laparoendoscopic single-site surgery (RLESS) aims to reduce port site morbidity.
Purpose of the Study:
- To evaluate the early experience and feasibility of simultaneous RLESS partial nephrectomy and robot-assisted laparoendoscopic radical prostatectomy (RALP).
- To assess the safety and efficacy of combining these two advanced robotic procedures in a single setting.
Main Methods:
- The study involved three patients with synchronous renal masses and prostate cancer.
- Simultaneous procedures included RLESS partial nephrectomy and standard RALP.
- Surgical outcomes and patient recovery were monitored.
Main Results:
- The feasibility of performing simultaneous RLESS partial nephrectomy and RALP was demonstrated.
- Early outcomes suggest this combined approach is viable for select patients.
- Further data collection is needed to fully establish the benefits and risks.
Conclusions:
- Simultaneous RLESS partial nephrectomy and RALP represent a potential advancement in treating patients with synchronous urologic malignancies.
- This combined approach may offer reduced morbidity compared to separate procedures.
- Further investigation is warranted to confirm the long-term efficacy and safety.

